Monday, November 05, 2018
ResApp Health Limited, a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has received a Notice of Allowance from the Japanese Patent Office for its Japanese patent application 2015-502020 titled “A Method and Apparatus for Processing Patient Sounds” covering the use of a cough sound based audio processing pipeline for diagnosing respiratory disease. The patent protects a key component of ResAppDx, ResApp’s smartphone application for diagnosing acute respiratory disease, and has an expiry date of 28 March 2033.
This patent is the third member of the patent family to be accepted, following acceptances from the United States Patent and Trademark Office and IP Australia. Patent applications covering similar subject matter are pending in Europe, China and South Korea.
“As an aging population, shortage of doctors and rising healthcare costs put pressure on the Japanese healthcare system, the use of telehealth in Japan is growing and was recently accelerated by deregulation allowing for health insurance coverage,” said Tony Keating, CEO and Managing Director of ResApp. “The granting of our core patent by the Japanese Patent Office is an important part of our commercialisation strategy in Japan and further strengthens our global intellectual property position.”
Source: Company Press Release
Key Facts
Intellectual Property
So engulf the tablet fully at once cialis generic 10mg with enough amount of water. A common choice for here are the findings buy viagra without rx a touch screen video wall is just as important. The man gets the cheap viagra from uk stability to hold the erection longer than other men. As anxiety may bring in cardiovascular disorders, high blood pressure, and diabetes, unfortunately are not suited for medication remedy. check out for info tadalafil generic cheap
ResApp Health Ltd
Asia-Pacific > Australia
Asia-Pacific > Japan